Drawing for VARITHENA

USPTO serial 79165788

VARITHENA

Reviewed by CopyMark Law Group

Reg. 4948523Status 739Registered
Filing date
Status date
Registration date
May 3, 2016
Examiner
LEE, IN PYO
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with VARITHENA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lori A. Ruhly

Lori A. Ruhly Quarles & Brady LLP33 East Main Street, Suite 900Madison, WI 53703United States

Goods and services

ClassDescriptionStatusFirst use
001[ Chemicals for use in the pharmaceutical industry; chemical substances for preserving foodstuffs; chemicals for use in the manufacture of pharmaceuticals for the treatment of angiologic disorders, particularly varicose veins; chemicals for use in the production of injectable foams ]SECTION 71 - CANCELLED—
005Pharmaceutical preparations for the treatment of varicose veins and arterio-venous malformations; pharmaceutical preparations for the treatment of vascular diseases; pharmaceutical products and preparations to prevent swelling in the legs; sanitary preparations for medical purposes; [ dietary supplements for humans and animals; medical plasters; materials for dressings, namely, adhesive bandages, medical and surgical adhesive tape; ] medical dressings; surgical dressings; wound dressings; pharmaceutical preparations in the form of foams and for use in preparing foams, for sclerotherapy, phlebology, angiology [ and proctology, for treatment of oesophageal varices, hydroceles, ] in sterilization treatment and for treatment of varicose veins, and arterio-venous malformationsACTIVE—
010* Surgical and medical apparatus for use in the treatment of varicose veins, arterio-venous malformation [, oesophageal varices and hydroceles ]; surgical and medical apparatus for use in sclerotherapy, phlebology, angiology [ and proctology, and for the treatment of oesophageal varices, hydroceles ], in sterilization treatment and for the treatment of varicose veins, and arterio-venous malformations; * Medical syringes; [ cannula needles for medical use; ] * medical tubing for administration of foams for sclerotherapy; medical tubing for administration of foams for the treatment of varicose veins, venose malformations,* and * arterio-venous malformations [, oesophageal varices and hydroceles ] ; * surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, * and * arterio-venous malformations [, oesophageal varices and hydroceles ] ; surgical and medical apparatus for producing and administering foams for use in sterilization treatment; surgical and medical apparatus for producing foams for use in sclerotherapy, phlebology, angiology and proctology, sterilization treatment and for * [ the ] * treatment of varicose veins, arterio-venous malformations, [ oesophageal varices and hydroceles; ] none of the aforementioned goods being supportive bandages or compression bandages; medical devices, namely, devices for assessing the physical characteristics of foams for use in sclerotherapy, phlebology, angiology and proctology, sterilization treatment and for treatment of varicose veins, * and * arterio-venous malformations, [ oesophageal varices and hydroceles, ] devices for intravenous administration of such foam [, and devices for monitoring the position and effect of such foam in the human body; medical diagnostic devices for use in all the above medical conditions ]ACTIVE—
042[ Design and development of computer hardware and software; computer programming; installation, maintenance and repair of computer software; computer consultancy services; scientific research services related to sclerotherapy of veins including provision of treatment in the fields of phlebology, proctology and angiology ]SECTION 71 - CANCELLED—
044[ Medical services; hygienic and beauty care for human beings or animals; medical analysis for the diagnosis and treatment of persons in the fields of sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; pharmaceutical advice; medical services for diagnosis in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical health assessment services, namely, providing post-treatment and homecare to patients in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical treatment services in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical after-care services in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 19, 2026NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Aug 19, 2026C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Aug 10, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 4, 2026ES75TEAS SECTION 71 & 15 RECEIVED—
May 3, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Dec 13, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 3, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 3, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 3, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 3, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 26, 2024CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jun 28, 2024RNWLINTERNATIONAL REGISTRATION RENEWED—
Mar 17, 2024INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Feb 2, 2024INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Feb 2, 2024INPCINVALIDATION PROCESSED—
Jan 20, 2024INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 23, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 22, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 22, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 22, 2023EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
May 22, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 22, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 22, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 20, 2023NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 20, 202371.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
May 20, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 2, 2022ES71TEAS SECTION 71 RECEIVED—
Jan 8, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 3, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 13, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 28, 2017INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Mar 22, 2017INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 17, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 9, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 9, 2016FIMPFINAL DISPOSITION PROCESSED—
Aug 3, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 22, 2016CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Jul 22, 2016COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Jul 22, 2016CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
May 3, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 29, 2016LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Mar 4, 2016LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Feb 16, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 16, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 13, 2016GPNXNOTIFICATION PROCESSED BY IB—
Jan 27, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 27, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 27, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 13, 2016CNEAEXAMINERS AMENDMENT MAILED—
Jan 13, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 13, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jan 13, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 12, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 12, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 7, 2016LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Jan 3, 2016LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Dec 11, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 9, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 9, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 4, 2015RFNTREFUSAL PROCESSED BY IB—
Jun 12, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 12, 2015RFRRREFUSAL PROCESSED BY MPU—
Jun 12, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 11, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 6, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 2, 2015DOCKASSIGNED TO EXAMINER—
Jun 2, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 30, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance